Biofrontera AG

XTRA:B8FK Stock Report

Market Cap: €14.3m

Biofrontera Future Growth

Future criteria checks 0/6

We currently don't have sufficient analyst coverage to forecast growth and revenue for Biofrontera.

Key information

n/a

Earnings growth rate

n/a

EPS growth rate

Pharmaceuticals earnings growth19.6%
Revenue growth raten/a
Future return on equityn/a
Analyst coverage

None

Last updatedn/a

Recent future growth updates

Recent updates

Biofrontera AG (ETR:B8FK) Not Doing Enough For Some Investors As Its Shares Slump 47%

May 21
Biofrontera AG (ETR:B8FK) Not Doing Enough For Some Investors As Its Shares Slump 47%

Why Investors Shouldn't Be Surprised By Biofrontera AG's (ETR:B8F) 30% Share Price Plunge

Mar 07
Why Investors Shouldn't Be Surprised By Biofrontera AG's (ETR:B8F) 30% Share Price Plunge

We're Keeping An Eye On Biofrontera's (ETR:B8F) Cash Burn Rate

Feb 19
We're Keeping An Eye On Biofrontera's (ETR:B8F) Cash Burn Rate

Here's Why It's Unlikely That Biofrontera AG's (ETR:B8F) CEO Will See A Pay Rise This Year

Dec 07
Here's Why It's Unlikely That Biofrontera AG's (ETR:B8F) CEO Will See A Pay Rise This Year

Does Biofrontera (ETR:B8F) Have A Healthy Balance Sheet?

Jun 08
Does Biofrontera (ETR:B8F) Have A Healthy Balance Sheet?

Biofrontera AG (ETR:B8F) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

Apr 14
Biofrontera AG (ETR:B8F) Consensus Forecasts Have Become A Little Darker Since Its Latest Report

In this section we usually present revenue and earnings growth projections based on the consensus estimates of professional analysts to help investors understand the company’s ability to generate profit. But as Biofrontera has not provided enough past data and has no analyst forecast, its future earnings cannot be reliably calculated by extrapolating past data or using analyst predictions.

This is quite a rare situation as 97% of companies covered by SimplyWall St do have past financial data.

Earnings and Revenue Growth Forecasts

XTRA:B8FK - Analysts future estimates and past financials data (EUR Millions)
DateRevenueEarningsFree Cash FlowCash from OpAvg. No. Analysts
3/31/2024300N/AN/AN/A
12/31/2023320-3-2N/A
9/30/202329-9N/AN/AN/A
6/30/202328-11-4-3N/A
3/31/202325-20N/AN/AN/A
12/31/202226-44-5-4N/A
9/30/20223211N/AN/AN/A
6/30/202231103333N/A
3/31/20223015N/AN/AN/A
12/31/202129383030N/A
9/30/202128-16N/AN/AN/A
6/30/202127-16-8-7N/A
3/31/202129-12N/AN/AN/A
12/31/202030-13-4-3N/A
9/30/202033-17N/AN/AN/A
6/30/202033-22-14-12N/A
3/31/202031-10N/AN/AN/A
12/31/201931-7-35-33N/A
9/30/2019261N/AN/AN/A
6/30/2019268-29-28N/A
3/31/201923-8N/AN/AN/A
12/31/201821-9-14-13N/A
9/30/201819-14-13-13N/A
6/30/201816-15-12-12N/A
3/31/201814-16N/AN/AN/A
12/31/201712-16N/A-13N/A
9/30/201711-18N/A-16N/A
6/30/20179-16N/A-16N/A
3/31/20178-14N/A-15N/A
12/31/20166-11N/A-10N/A
9/30/20164-9N/A-8N/A
6/30/20164-7N/A-6N/A
3/31/20164-9N/A-8N/A
12/31/20154-11N/A-10N/A
9/30/20154-12N/A-10N/A
6/30/20153-13N/A-10N/A
3/31/20153-10N/A-7N/A
12/31/20143-11N/A-8N/A
9/30/20143-10N/A-8N/A
6/30/20143-10N/A-7N/A
3/31/20143-9N/A-7N/A
12/31/20133-8N/A-7N/A
9/30/20133-8N/A-7N/A

Analyst Future Growth Forecasts

Earnings vs Savings Rate: Insufficient data to determine if B8FK's forecast earnings growth is above the savings rate (0.8%).

Earnings vs Market: Insufficient data to determine if B8FK's earnings are forecast to grow faster than the German market

High Growth Earnings: Insufficient data to determine if B8FK's earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: Insufficient data to determine if B8FK's revenue is forecast to grow faster than the German market.

High Growth Revenue: Insufficient data to determine if B8FK's revenue is forecast to grow faster than 20% per year.

Earnings per Share Growth Forecasts

Future Return on Equity

Future ROE: Insufficient data to determine if B8FK's Return on Equity is forecast to be high in 3 years time

Discover growth companies

7D

1Y

7D

1Y

7D

1Y